Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
November 01, 2022 09:10 ET
|
Myriad Genetics, Inc.
$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal productsFast-growing SneakPeek test has helped 750,000 parents learn baby’s gender from home – earliest...
Start-Ups Take Center Stage at Happy Mama Expo's Maternity Tech Innovation Showcase
October 05, 2022 11:46 ET
|
Reach Healthcare
SAN DIEGO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- There is something for everyone at the Happy Mama Expo, Saturday, October 22nd from 7 AM to 7 PM Eastern. Topics range from prenatal and postpartum...
United Kingdom Non-Invasive Prenatal Testing Market Research Report 2022: Competitive Developments, Approaches, Recent Developments, M&A, Collaborations, Partnerships, Distribution, and Licensing
August 11, 2022 04:03 ET
|
Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "United Kingdom Non-Invasive Prenatal Testing Market and Forecasts 2022 - 2028" report has been added to ResearchAndMarkets.com's offering. The United...
Global Down Syndrome Foundation, the National Down Syndrome Congress, and the National Down Syndrome Society Highlight the FDA’s Public Warning About Risks Associated with Non-Invasive Prenatal Screening Tests
April 27, 2022 13:00 ET
|
Global Down Syndrome Foundation
Atlanta, Denver, New York, April 27, 2022 (GLOBE NEWSWIRE) -- Last week, the U.S. Food and Drug Administration (FDA) warned the public of the risk of false results, inappropriate use, and...
First Mom and Baby In-Utero Fetal Surgery in Utah Reunited with Intermountain Primary Children’s and U of U Health Medical Team
April 13, 2022 13:40 ET
|
Intermountain Healthcare
Salt Lake City, April 13, 2022 (GLOBE NEWSWIRE) -- One year after a specialized medical team at Intermountain Primary Children’s Hospital and University of Utah Health performed the first in-utero...
Global Non-Invasive Prenatal Testing (NIPT) Market Report 2022-2027: Cell-Free DNA-Based NIPT Market Is Gauged to Generate the Highest Market Share
April 07, 2022 05:58 ET
|
Research and Markets
Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Global Non-Invasive Prenatal Testing (NIPT) Market, Forecast 2022-2027, Industry Trends, Growth, Insight, Impact of COVID-19, Company Analysis" report...
United States Non-Invasive Prenatal Testing (NIPT) Markets, 2021-2022 & 2030: Growing Focus on Reimbursement for Non-invasive Prenatal Testing
March 28, 2022 04:33 ET
|
Research and Markets
Dublin, March 28, 2022 (GLOBE NEWSWIRE) -- The "United States Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast...
Global Non-invasive Prenatal Testing Market Forecast to Reach $7.34 Billion in 2026 at a CAGR of 14.9%
March 17, 2022 06:38 ET
|
Research and Markets
Dublin, March 17, 2022 (GLOBE NEWSWIRE) -- The "Non-invasive Prenatal Testing Global Market Report 2022, By Type, By End User, By Instruments, By Consumables, By Application" report has been added...
China $825 Million Non-Invasive Prenatal Testing Markets to 2028
March 01, 2022 04:23 ET
|
Research and Markets
Dublin, March 01, 2022 (GLOBE NEWSWIRE) -- The "China Non-Invasive Prenatal Testing Market Size, Trends, Share, Growth, Opportunity, and Forecast 2022 - 2028" report has been added to...
Indian Non-Invasive Prenatal Testing (NIPT) Market 2022 - 2028: A $62 Million Market by 2028
January 26, 2022 04:16 ET
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "India Non-Invasive Prenatal Testing (NIPT) Market and Forecast 2022 - 2028" report has been added to ResearchAndMarkets.com's offering. The Indian...